Business · 05/09/2003
FDA's Manufacturing Subcommittee Proposes Changes to Pharmaceutical Notice
The FDA's Manufacturing Subcommittee of the Advisory Committee for Pharmaceutical Science is proposing amendments to a notice related to pharmaceutical manufacturing, aiming to improve the quality and safety of pharmaceutical products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →